| abstract |
The present invention relates to thiirane or Michael acceptor compounds, including the compounds of formula (I) as described and defined herein, and pharmaceutical compositions comprising these compounds, as well as their medical use, particularly their use in the treatment or prevention of a bacterial infection, including, e.g., an infection with multidrug-resistant Staphylococcus aureus. |